{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:00:17Z","timestamp":1788642017696,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cger.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T07:44:19Z","timestamp":1629963859000},"page":"85-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Abuse\/Misuse of Prescription Medications in Older Adults"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1124-9720","authenticated-orcid":false,"given":"Esra","family":"Ates Bulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5867-6503","authenticated-orcid":false,"given":"Ahmet Turan","family":"ISIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0749-0690(18)30503-2","article-title":"Overcoming problems with polypharmacy and drug misuse in the elderly","volume":"8","author":"Montamat","year":"1992","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.cger.2021.07.004_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/CIA.S159966","article-title":"Costs of medication in older patients: before and after comprehensive geriatric assessment","volume":"13","author":"Unutmaz","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12877-019-1263-3","article-title":"Impact of training and structured medication review on medication appropriateness and patient-related outcomes in nursing homes: results from the interventional study InTherAKT","volume":"19","author":"Mahlknecht","year":"2019","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ejhpharm-2016-001044","article-title":"Polypharmacy management programmes: the SIMPATHY Project","volume":"24","author":"Mair","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"10081","key":"10.1016\/j.cger.2021.07.004_bib6","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","article-title":"The prescribing cascade revisited","volume":"389","author":"Rochon","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cger.2021.07.004_bib7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1532-5415.2009.02329.x","article-title":"Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people","volume":"57","author":"Nahin","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"sup1","key":"10.1016\/j.cger.2021.07.004_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/21548331.2019.1706995","article-title":"Polypharmacy in older adults: the role of the multidisciplinary team","volume":"48","author":"Baruth","year":"2020","journal-title":"Hosp Pract (1995)"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.cger.2021.07.004_bib10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/CIA.S180281","article-title":"Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017","volume":"13","author":"Ates Bulut","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib11","first-page":"32","article-title":"Polypharmacy: evaluating risks and deprescribing","volume":"100","author":"Halli-Tierney","year":"2019","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American geriatrics society 2019 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12877-021-02141-w","article-title":"Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study","volume":"21","author":"Piccoliori","year":"2021","journal-title":"BMC Geriatr"},{"issue":"9","key":"10.1016\/j.cger.2021.07.004_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cger.2021.07.004_bib15","series-title":"Drug abuse and addiction in medical Illness: causes, consequences and treatment","first-page":"213","article-title":"Prescription drug misuse across the lifespan: a developmental perspective","author":"McLarnon","year":"2012"},{"issue":"12","key":"10.1016\/j.cger.2021.07.004_bib16","doi-asserted-by":"crossref","first-page":"e009235","DOI":"10.1136\/bmjopen-2015-009235","article-title":"Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review","volume":"5","author":"Cooper","year":"2015","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.cger.2021.07.004_bib17","article-title":"Interventions to improve the appropriate use of polypharmacy for older people","volume":"9","author":"Rankin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cger.2021.07.004_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.cger.2021.07.004_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40266-013-0146-0","article-title":"Consensus validation of the FORTA (Fit fOR the Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly","volume":"31","author":"Kuhn-Thiel","year":"2014","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1016\/j.cger.2021.07.004_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0895-4356(92)90144-C","article-title":"A\u00a0method for assessing drug therapy appropriateness","volume":"45","author":"Hanlon","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"8 Pt 2","key":"10.1016\/j.cger.2021.07.004_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.7326\/0003-4819-135-8_Part_2-200110161-00002","article-title":"Assessing care of vulnerable elders: ACOVE project overview","volume":"135","author":"Wenger","year":"2001","journal-title":"Ann Intern Med"},{"issue":"31\u201332","key":"10.1016\/j.cger.2021.07.004_bib22","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"10.1016\/j.cger.2021.07.004_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.cger.2021.07.004_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jalz.2012.02.005","article-title":"Long-term anticholinergic use and the aging brain","volume":"9","author":"Cai","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.cger.2021.07.004_bib26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A\u00a0drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.cger.2021.07.004_bib27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40266-018-0584-9","article-title":"Association of anticholinergic drug burden with cognitive and functional decline over time in older inpatients: results from the CRIME project","volume":"35","author":"Brombo","year":"2018","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.cger.2021.07.004_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/bcp.12617","article-title":"Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis","volume":"80","author":"Ruxton","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"14","key":"10.1016\/j.cger.2021.07.004_bib29","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.2010.1482","article-title":"Managing medications in clinically complex elders: \"There's got to be a happy medium","volume":"304","author":"Steinman","year":"2010","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.cger.2021.07.004_bib30","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.pain.2013.05.053","article-title":"Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations","volume":"154","author":"Smith","year":"2013","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.cger.2021.07.004_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.genm.2010.09.004","article-title":"Gender effects on drug use, abuse, and dependence: a special analysis of results from the National Survey on drug use and health","volume":"7","author":"Cotto","year":"2010","journal-title":"Gend Med"},{"issue":"9","key":"10.1016\/j.cger.2021.07.004_bib32","first-page":"22","article-title":"Prescription drug misuse\/abuse in the elderly","volume":"63","author":"Culberson","year":"2008","journal-title":"Geriatrics"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjopharm.2006.10.002","article-title":"Psychoactive drug abuse in older adults","volume":"4","author":"Simoni-Wastila","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.cger.2021.07.004_bib34","series-title":"Results from the 2019 national survey on drug use and health: detailed tables","year":"2020"},{"issue":"8","key":"10.1016\/j.cger.2021.07.004_bib35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199008233230805","article-title":"Geriatrics: sleep disorders and aging","volume":"323","author":"Prinz","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 9","key":"10.1016\/j.cger.2021.07.004_bib36","first-page":"31","article-title":"Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds","volume":"66","author":"Griffiths","year":"2005","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.cger.2021.07.004_bib38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cger.2021.07.004_bib39","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"issue":"166","key":"10.1016\/j.cger.2021.07.004_bib41","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","author":"Chen","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.cger.2021.07.004_bib42","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cger.2021.07.004_bib43","series-title":"U.S acting secretary declares public health emergency to address national opioid crisis","year":"2017"},{"issue":"15","key":"10.1016\/j.cger.2021.07.004_bib44","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamainternmed.2015.7799","article-title":"Effect of US drug enforcement administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing","volume":"176","author":"Jones","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2s","key":"10.1016\/j.cger.2021.07.004_bib46","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.36076\/ppj.2017.s109","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"issue":"10","key":"10.1016\/j.cger.2021.07.004_bib47","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/pm\/pnz304","article-title":"Prescription opioid misuse Motives in US older adults","volume":"21","author":"Schepis","year":"2020","journal-title":"Pain Med"},{"issue":"7","key":"10.1016\/j.cger.2021.07.004_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40263-013-0084-8","article-title":"Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management","volume":"27","author":"Spiller","year":"2013","journal-title":"CNS drugs"},{"issue":"6","key":"10.1016\/j.cger.2021.07.004_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1192\/apt.bp.108.006221","article-title":"Drug misuse in older people: old problems and new challenges","volume":"16","author":"Badrakalimuthu","year":"2010","journal-title":"Adv Psychiatr Treat"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib50","first-page":"247","article-title":"Prescription sedative misuse and abuse","volume":"88","author":"Weaver","year":"2015","journal-title":"Yale J Biol Med"},{"issue":"13","key":"10.1016\/j.cger.2021.07.004_bib51","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1503\/cmaj.131534","article-title":"Bupropion abuse and overdose","volume":"186","author":"Stall","year":"2014","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00952990.2019.1599382","article-title":"Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States","volume":"45","author":"Leonard","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.cger.2021.07.004_bib53","first-page":"39","article-title":"Emergency department visits involving misuse and abuse of the antipsychotic quetiapine: results from the drug abuse warning network (DAWN)","volume":"9","author":"Mattson","year":"2015","journal-title":"Subst Abuse"},{"issue":"5","key":"10.1016\/j.cger.2021.07.004_bib54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/JCP.0b013e3182670648","article-title":"Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program","volume":"32","author":"McLarnon","year":"2012","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.cger.2021.07.004_bib55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/14659891.2013.810309","article-title":"Quetiapine abuse and dependence in psychiatric patients: a systematic review of 25 case reports in the literature","volume":"19","author":"Cuba\u0142a","year":"2014","journal-title":"J\u00a0Substance Use"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(02)02044-7","article-title":"Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex","volume":"449","author":"van Hooft","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/02791072.2020.1802087","article-title":"Descriptions of gabapentin misuse and associated behaviors among a sample of opioid (Mis)users in south Florida","volume":"53","author":"Buttram","year":"2021","journal-title":"J\u00a0Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.cger.2021.07.004_bib58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.cger.2021.07.004_bib59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jnnp-2012-303988","article-title":"Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome","volume":"85","author":"Cilia","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.cger.2021.07.004_bib61","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jagp.2016.06.003","article-title":"A\u00a0systematic review of opioid and benzodiazepine misuse in older adults","volume":"24","author":"Maree","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.cger.2021.07.004_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A\u00a0history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib63","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1185\/030079908X273435","article-title":"Non-medical use and abuse of commonly prescribed medications","volume":"24","author":"Riggs","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.cger.2021.07.004_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7326\/M13-2209","article-title":"Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians","volume":"160","author":"Kirschner","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069021000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:57:40Z","timestamp":1760061460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069021000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0749069021000665"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2021.07.004","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abuse\/Misuse of Prescription Medications in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}